These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28565873)

  • 41. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
    Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
    PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs in the development and neoplasia of the mammary gland.
    Jena MK
    F1000Res; 2017; 6():1018. PubMed ID: 28979765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells.
    Sengupta S; Sharma CG; Jordan VC
    Horm Mol Biol Clin Investig; 2010 Aug; 2(2):235-243. PubMed ID: 21297881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-148a-3p promotes survival and migration of endothelial cells isolated from Apoe deficient mice through restricting circular RNA 0003575.
    Shang L; Quan A; Sun H; Xu Y; Sun G; Cao P
    Gene; 2019 Aug; 711():143948. PubMed ID: 31255737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
    Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.
    Adams BD; Furneaux H; White BA
    Mol Endocrinol; 2007 May; 21(5):1132-47. PubMed ID: 17312270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
    Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
    Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer.
    Liu Y; Ma H; Wang Y; Du X; Yao J
    Onco Targets Ther; 2019; 12():11359-11369. PubMed ID: 31920327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional activation of Nlp by estrogen-ERα in breast cancer.
    Li J; Chen J; Xue L; Zhan Q
    Sci Bull (Beijing); 2017 Nov; 62(21):1445-1454. PubMed ID: 36659394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ERRATUM.
    Zhao M; Su Z; Zhang S; Zhuang L; Xie Y; Li X
    Oncol Res; 2017 Jan; 25(1):155. PubMed ID: 28081744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-148a promotes cell sensitivity through downregulating SOS2 in radiation-resistant non-small cell lung cancer cells.
    Zhang Y; Hu X
    Oncol Lett; 2022 Apr; 23(4):135. PubMed ID: 35251354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysregulation of the miR-148a-GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma.
    Tiemin P; Peng X; Qingfu L; Yan W; Junlin X; Zhefeng H; Ming Z; Desen L; Qinghui M
    Oncogenesis; 2020 Feb; 9(2):19. PubMed ID: 32054829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1.
    Zhang SL; Liu L
    Exp Ther Med; 2015 Feb; 9(2):579-584. PubMed ID: 25574238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis.
    Maximov P; Sengupta S; Lewis-Wambi JS; Kim HR; Curpan RF; Jordan VC
    Horm Mol Biol Clin Investig; 2011 Mar; 5(1):27-34. PubMed ID: 21660224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen Regulates Mitochondrial Morphology through Phosphorylation of Dynamin-related Protein 1 in MCF7 Human Breast Cancer Cells.
    Oo PS; Yamaguchi Y; Sawaguchi A; Tin Htwe Kyaw M; Choijookhuu N; Noor Ali M; Srisowanna N; Hino SI; Hishikawa Y
    Acta Histochem Cytochem; 2018 Feb; 51(1):21-31. PubMed ID: 29622847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1.
    Pan B; Zheng L; Liu S; Fang J; Lou C; Hu X; Ye L; Lai H; Gao J; Zhang Y; Ni K; He D
    Cell Death Discov; 2022 Nov; 8(1):470. PubMed ID: 36446758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells.
    Chang YC; Cheung CHA; Kuo YL
    Front Cell Dev Biol; 2020; 8():485. PubMed ID: 32695778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation.
    Meng C; Liu Y; Shen Y; Liu S; Wang Z; Ye Q; Liu H; Liu X; Jia L
    Oncol Lett; 2018 Feb; 15(2):1435-1440. PubMed ID: 29399189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-Catenin Is a Positive Regulator of Estrogen Receptor-α Function in Breast Cancer Cells.
    Gupta N; Schmitt F; Grebhardt S; Mayer D
    Cancers (Basel); 2011 Jul; 3(3):2990-3001. PubMed ID: 24212942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.